140 related articles for article (PubMed ID: 3576612)
1. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
2. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats.
Mansour MA; Mostafa AM; Nagi MN; Khattab MM; Al-Shabanah OA
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jun; 132(2):123-8. PubMed ID: 12106889
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.
Dickey DT; Muldoon LL; Doolittle ND; Peterson DR; Kraemer DF; Neuwelt EA
Cancer Chemother Pharmacol; 2008 Jul; 62(2):235-41. PubMed ID: 17909806
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
[TBL] [Abstract][Full Text] [Related]
7. Relationship between age and nephrotoxicity following single low-dose cisplatin (CDDP) injection in rats.
Namikawa K; Kinsoku A; Minami T; Okazaki Y; Kadota E; Teramura K; Hashimoto S
Biol Pharm Bull; 1995 Jul; 18(7):957-62. PubMed ID: 7581250
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
9. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
[TBL] [Abstract][Full Text] [Related]
10. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats.
Nematbakhsh M; Ashrafi F; Safari T; Talebi A; Nasri H; Mortazavi M; Khazaei M; Baradaran-Mahdavi MM
J Nephrol; 2012; 25(3):410-7. PubMed ID: 21928232
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times.
Xu YY; Jiang N; Liu TS; Qu HQ; Wang T
Mol Med Rep; 2012 Nov; 6(5):1075-80. PubMed ID: 22895541
[TBL] [Abstract][Full Text] [Related]
12. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
[TBL] [Abstract][Full Text] [Related]
14. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Low Dose Vorinostat on Cisplatin-Induced Nephrotoxicity in Rats.
Bashraf OMO; Ali AS; Eweis HSA; Ali SS
Curr Mol Pharmacol; 2021 Oct; 14(4):635-645. PubMed ID: 33297925
[TBL] [Abstract][Full Text] [Related]
16. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
17. Acute renal failure following intraperitoneal injection of cis-diamminedichloroplatinum.
Hosokawa S; Kohira S; Tomotoshi T
Urol Int; 1984; 39(4):246-9. PubMed ID: 6541388
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury.
Saleh S; Ain-Shoka AA; El-Demerdash E; Khalef MM
Chemotherapy; 2009; 55(6):399-406. PubMed ID: 19955745
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
